System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Luca Baldetti is an expert in Cardiology at IRCCS Ospedale San Raffaele (Italy). Luca Baldetti has authored 184 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 2 of them ongoing. SLR score: 746 (community average: 125). How the SLR is computed.

LeadR Profile

Luca Baldetti IRCCS Ospedale San Raffaele Italy
746 ScienceLeadR Reputation 746

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Transplantation - Public Health - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2017 - 2026
Source: PubMed

IRCCS Ospedale San Raffaele

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 184

Citations

Citations: 2 211 1st author: 53 Last author: 5 Unique author: 0

Main journals

JACC Cardiovasc Interv 18
J Am Coll Cardiol 16
Eur Heart J Suppl 13
J Heart Lung Transplant 12
Can J Cardiol 9

Best Journals

Eur Heart J 3
Circulation 2
N Engl J Med 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Between Physiology and Practice Culture: Unresolved Variability of Vasoactive Therapy in Cardiogenic Shock.
PMID 42743343 — physiology, shock, cardiogenic, heart failure, uncertainty, therapeutics		Circ Heart Fail20261
Managing Cardiogenic Shock in the Era of Multimodal Mechanical Support: Bridging to Transplant or Recovery.
PMID 42635874 — shock, cardiogenic, heart failure, heart, phenotype, recycling, transplants, mechanical circulatory support		Curr Heart Fail Rep20260
Carboxyhemoglobin as a biomarker of hemolysis: A systematic review and meta-analysis.
PMID 42619001 — extracorporeal membrane oxygenation, biomarkers, carboxyhemoglobin, hemolysis		Int J Artif Organs20260
Clinical congestion patterns in patients with advanced heart failure: an analysis of the HELP-HF Registry.
PMID 42485116 — registries, mortality, hospitalization, heart failure, heart, cardiovascular diseases		J Cardiovasc Med (Hagerstown)20260
Optimizing revascularization in the high-risk heart: Impella™-facilitated percutaneous coronary intervention in multivessel coronary artery disease with reduced left ventricular ejection fraction and mitral regurgitation.
PMID 42368213 — mortality, coronary artery disease, heart, percutaneous coronary intervention, arteries, coronary artery bypass, frailty, mitral valve insufficiency		Eur Heart J Suppl20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 2 1
Phase 4 1

By status:

Recruiting 3
Completed 1

By type:

Interventional 2
Observational 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Abiomed Impella RT DAQ Observational Study
NCT06308055 — shock, cardiogenic, pulmonary artery, arteries, algorithms, cardiac output, hemodynamics, catheters		N/ARecruiting2024
Cangrelor on Top of AnticoagUlation in Patients with MyocaRdial Infarction related Cardiogenic Shock Cardiac Arrest ReceiVIng VA ECMO
NCT06792643 — safety, myocardial infarction, shock, cardiogenic, heart, extracorporeal membrane oxygenation, acute coronary syndrome, heart arrest, therapeutics, blood platelets, membranes		Phase 2Recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS